Yu Gu

ORCID: 0000-0003-3055-6248
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vasculitis and related conditions
  • Protein Degradation and Inhibitors
  • Sarcoidosis and Beryllium Toxicity Research
  • Cancer Genomics and Diagnostics
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Adrenal and Paraganglionic Tumors
  • Hormonal Regulation and Hypertension
  • Gastric Cancer Management and Outcomes
  • Analytical Chemistry and Sensors
  • IgG4-Related and Inflammatory Diseases
  • Chemical Synthesis and Reactions
  • Lung Cancer Treatments and Mutations
  • Anesthesia and Neurotoxicity Research
  • Advanced Breast Cancer Therapies
  • Pancreatic and Hepatic Oncology Research
  • Ferroptosis and cancer prognosis
  • Ovarian cancer diagnosis and treatment
  • Gastrointestinal Tumor Research and Treatment
  • Genomics and Rare Diseases

Chinese Academy of Medical Sciences & Peking Union Medical College
2019-2024

Peking Union Medical College Hospital
2019-2024

Meeting abstracts Despite improvements in diagnosis, surgical techniques, and multidisciplinary approaches to patient care, the median survival of patients with metastatic gastroesophageal adenocarcinoma is less than one year. Chemotherapy mainstay treatment

10.1186/2051-1426-3-s2-p157 article EN cc-by Journal for ImmunoTherapy of Cancer 2015-11-04

<h3>Introduction</h3> Expression of the immunoglobulin superfamily member CD112was increased in multiple malignancies. Importantly, its expression was observed both PD-L1negative and positive tumors. However, role CD112 tumorigenesis tumor development cervical cancer has not been elucidated. <h3>Methods</h3> The tissues detected using immunohistochemistry (IHC) gene profiling. CCK-8, edu tests, wound healing migration assays were used to assess biological effects overexpression knockdown....

10.1136/ijgc-2023-igcs.167 article EN 2023-11-01
Coming Soon ...